Evidence map›Paper›PMID 39118744›Full record

ReviewAnnals of medicine and surgery (2012)2024

National burden of Ebola virus disease in Democratic Republic of the Congo: the urgency to act.

Bilal Ahmad, Martin Sagide, Sylivia Ntamwinja, Elysée Byiringiro, Elie Kihanduka, Excellent Rugendabanga, Samson Hangi, Priyadarshini Bhattacharjee, Babar Ali, Marie Nkundakozera and 6 more

Abstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. The Antiviral Activity of Polyphenols.Molecular nutrition & food research · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Bilal AhmadDepartment of Community Medicine and Public Health, Shaikh Khalifa bin Zayed Al Nahyan Medical and Dental College.
Martin SagideJomo Kenyatta University of Agriculture and Technology, Juja.
Sylivia NtamwinjaFaculty of Medicine, Kenya Methodist University.
Elysée ByiringiroDepartment of Internal Medicine, Kibagabaga District Hospital, Kigali, Rwanda.
Elie KihandukaDepartment of Research, Medical Research Circle (MedReC), Bukavu.
Excellent RugendabangaDepartment of Research, Medical Research Circle (MedReC), Bukavu.
Samson HangiDepartment of Research, Medical Research Circle (MedReC), Bukavu.
Priyadarshini BhattacharjeeDepartment of Clinical Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Babar AliThe University of Lahore.
Marie NkundakozeraFaculty of Medicine, University of Goma.
Michée Sanza KandaMinistry of Health, Kinshasa, DR Congo.
Lucie GurukaFaculty of Medicine, University of Goma.
Jones OnesimeDepartment of Research, Medical Research Circle (MedReC), Bukavu.
Christian TagueFaculty of Medicine, Université Libre des Pays des Grands Lacs, Goma.
Amos Kipkorir LangatPan African University for Basic Sciences Technology and innovation, Nairobi, Kenya.
Aymar AkilimaliDepartment of Research, Medical Research Circle (MedReC), Bukavu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ebola virus disease (EVD) has long been a major public health concern for Democratic Republic of the Congo (DR Congo). First identified in DR Congo in 1976, the country has witnessed more than 25 outbreaks of this deadly disease, which has a case fatality rate of nearly 90% and manifesting with symptoms such as diarrhoea, vomiting, stomachache and haemorrhagic fever. African fruit bats have been speculated to be the reservoir of this virus. DR Congo is currently facing another EVD outbreak simultaneously with other communicable diseases, rendering it vulnerable to a shortage of medical and paramedical staff along with distrust among remote communities towards local authorities due to armed conflict and political instability. Moreover, lack of ring vaccinations and inefficient surveillance of suspected individuals are some other significant hurdles in disease control. Despite the availability of rVSV-ZEBOV/Erbevo vaccine and many antibody-based vaccines, challenges including politicization, low access to remote communities, and illiteracy have limited their effectiveness. Recently, the Congolese govt. has put in efforts such as building local capacities at the health zone level, outbreak control intervention, community engagement and social mobilization to counter the rising EVD cases. Four successive Strategic Response Plans have been implemented to increase resource mobilization by DR Congo and her partners. The Spread of zoonotics such as EVD can be confronted by implementing the One Health approach, which involves medical staff, veterinarians and public health officials.

Indexed as

Democratic Republic of the CongodiseaseEbola virus diseaseepidemiologyrisk factors

Identifiers

PMID39118744
PMCPMC11305799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.